Lyka Labs

Lyka Labs Limited is a pharmaceutical company that focuses on the development, manufacturing, and marketing of quality finished medicines. The company operates on a core belief in innovation, providing state-of-the-art solutions to maintain relevance and encourage experimentation. It has a well-diversified business model that spans across different markets, medical therapies, and a wide range of products. Key manufactured products include Dry Powder, Liquid, and Lyophilised Injections, which are supplied to both Indian and global markets. A primary strategy is investing in building brands and distribution networks for its human and veterinary healthcare businesses. This strategy supported a significant financial recovery, as the company reported a consolidated net profit of ₹811.40 lakhs against a net loss previously.;